Next Article in Journal
Oncoplastic Breast Surgery versus Conservative Mastectomy in the Management of Large Ductal Carcinoma In Situ (DCIS): Surgical, Oncological, and Patient-Reported Outcomes
Previous Article in Journal
A Narrative Review of the Usefulness of Indocyanine Green Fluorescence Angiography for Perfusion Assessment in Colorectal Surgery
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Minimally Invasive Distal Pancreatectomy Techniques: A Contemporary Analysis Exploring Trends, Similarities, and Differences to Open Surgery

1
Department of Surgery, University of California, San Francisco, CA 94143, USA
2
Department of Surgery, Division of Surgical Oncology, University of California, San Francisco, CA 94143, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Cancers 2022, 14(22), 5625; https://doi.org/10.3390/cancers14225625
Submission received: 2 October 2022 / Revised: 28 October 2022 / Accepted: 8 November 2022 / Published: 16 November 2022
(This article belongs to the Section Cancer Informatics and Big Data)

Abstract

:

Simple Summary

While the adoption of minimally invasive pancreatectomy had lagged, it has become more mainstream in recent years. Hand-assisted laparoscopic technique, an adjunct to laparoscopic surgery may offer the benefits of a total laparoscopic approach while mitigating the technical challenges associated with it. Previous studies investigating the different approaches in distal pancreatectomy have predominately focused on comparing outcomes between total laparoscopic (LDP) vs. open distal pancreatectomy (ODP); however, limited research has focused on outcomes associated with the hand-assisted distal pancreatectomy (HALDP) approach. This study demonstrates that compared to ODP, LDP was associated with improved surgical site infection rates. There was no difference in surgical site infection rates between ODP and HALDP. LDP was associated with longer operative times (+10 min only). Surgeon comfort and experience should decide the operative approach, but it is important to discuss the differences between these approaches with patients.

Abstract

Limited contemporary data has compared similarities and differences between total laparoscopic (LDP), hand-assisted (HALDP), and open distal pancreatectomy (ODP). This study aimed to examine similarities and differences in outcomes between these three approaches in a contemporary cohort. Methods: Patients undergoing elective LDP, HALDP, and ODP in the NSQIP dataset (2014–2019) were included. Descriptive statistics and multivariate regression analyses were employed to compare postoperative outcomes. Results: Among 5636 patients, 33.9% underwent LDP, 13.1% HALDP, and 52.9% ODP. Compared with the LDP approach, surgical site infections were more frequent in HALDP and ODP approaches (1.2% vs. 2.6% vs. 2.8%, respectively, p < 0.01). After adjustment, the LDP approach was associated with a significantly lower likelihood of surgical site infection (OR 0.25, p = 0.03) when compared to ODP. There was no difference in the likelihood of surgical site infection when HALDP was compared to ODP (OR 0.59, p = 0.40). Unadjusted operative times were similar between approaches (LDP = 192 min, HALDP = 193 min, ODP = 191 min, p = 0.59). After adjustment, the LDP approach had a longer operative time (+10.3 min, p = 0.04) compared to ODP. There was no difference in the adjusted operative time between HALDP and ODP approaches (+5.4 min, p = 0.80). Conclusions: Compared to ODP, LDP was associated with improved surgical site infection rates and slightly longer operative times. There was no difference in surgical site infection rates between ODP and HALDP. Surgeon comfort and experience should decide the operative approach, but it is important to discuss the differences between these approaches with patients.

1. Introduction

Minimally invasive surgery (MIS) techniques have been widely adopted across multiple surgical fields and are now considered the standard of care for many procedures, such as laparoscopic cholecystectomy and appendectomy [1,2]. However, the adoption of MIS for pancreatectomy has lagged. One explanation could be the technical difficulty of approaching the pancreas laparoscopically, due to its retroperitoneal location alongside major vascular structures [3]. However, recent studies have shown favorable results regarding the short-term benefits and safety of laparoscopic distal pancreatectomy, including lower surgical site infection rates, reduced blood loss, and shorter length of hospital stay, while maintaining comparable efficacy to the open approach (ODP) [3,4,5].
The hand-assisted laparoscopic technique, an adjunct to laparoscopic surgery, may offer the benefits of a total laparoscopic approach while mitigating the technical challenges associated with it. Hand-assisted surgery is performed through the placement of a hand-port to allow the insertion of the surgeon’s hand into the peritoneal cavity [6]. Hand-assisted techniques allow for improved tactile sensation and distance perception and increase the ease with which surgical specimens are removed from the abdominal cavity [7,8,9]. Furthermore, it may allow faster response in the event of unexpected bleeding and facilitate suture ligation, which could explain the reduction in intraoperative blood loss and operative times reported in some studies [8,9,10]. However, large population-based studies comparing minimally invasive approaches in the setting of colectomy have demonstrated an increased risk of surgical site infection with hand-assisted colectomy, challenging the premise that hand-assisted surgery carries the same risks as a total laparoscopic approach [10,11,12,13].
Previous studies investigating the different surgical techniques in distal pancreatectomy have predominately focused on comparing outcomes between total laparoscopic (LDP) vs. open distal pancreatectomy (ODP); however, limited research has focused on outcomes associated with the hand-assisted distal pancreatectomy (HALDP) approach [13,14], especially in the modern era where minimally invasive distal pancreatectomy techniques have become more accepted, beyond the early learning curve. Given the lack of comparisons between these approaches and prior evidence suggesting minimal differences in operative times [10] and increased overall risk of surgical site infection in the setting of colectomy [10,12,13], the objective of this study was to examine the surgical site infection rates and operative times across LDP, HALDP, and ODP for distal pancreatectomy utilizing a large national database.

2. Materials and Methods

2.1. Data Source and Study Cohort

The American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) database was queried to identify all patients who underwent elective minimally invasive (HALDP and LDP) and open distal pancreatectomy (ODP) (CPT codes 48140 and 48146) from 2014 to 2019 [15]. Patients younger than 18 years old and who had preoperative jaundice or biliary stenting, ascites, preoperative infection (superficial/deep surgical site infection, abscess, pneumonia, or urinary tract infection), were ventilator-dependent, on hemodialysis, or who underwent vascular resection were excluded. To ensure that the outcomes of interest were only driven by the distal pancreatectomy, patients who underwent other major concurrent or additional surgical procedures during the same general anesthetic event as the distal pancreatectomy were excluded from the analysis. Variables extracted from the database included: patient age, sex, race, ethnicity, diagnosis, pathological stage (T, N, and M stages), neoadjuvant therapy, baseline comorbidities, preoperative albumin levels, operative time, gland texture, postoperative complications, length of stay, need for reoperation, 30-day readmission, and 30-day mortality. Due to the de-identified nature of the dataset, this study was granted exemption status by our Institutional Review Board.

2.2. Primary and Secondary Endpoints

The primary endpoints were the occurrence of surgical site infection and operative time. Secondary endpoints included composite overall complications, composite significant complications, clinically relevant (B/C) postoperative pancreatic fistula formation, postoperative transfusion, discharge to facility, and length of hospital stay. A composite of overall complications was created and included infectious (deep wound infection and dehiscence, abscess, urinary tract infection, post-operative sepsis, and/or post-operative septic shock), pulmonary (pneumonia, reintubation and/or ventilator wean failure), cardiovascular (deep vein thrombosis, pulmonary embolism, stroke, cardiac arrest, and/or myocardial infarction) and renal complications (acute renal failure), post-operative blood transfusion, reoperation, 30-day readmission, and 30-day mortality. Urinary tract infection and acute renal failure were excluded from the overall complications composite to create the significant complications composite variable.

2.3. Statistical Analysis

Descriptive statistics for patients’ demographic, preoperative, and intraoperative characteristics and postoperative outcomes were compared between patients undergoing LDP, HALDP, and ODP surgery. For continuous variables, the nonparametric Kruskal–Wallis test was used and for categorical variables, the χ2 test was employed.
The association between each covariate (patient age, sex, race, ethnicity, neoadjuvant therapy, baseline comorbidities (diabetes, smoking, dyspnea, functional status, COPD, ascites, CHF, hypertension requiring medication, bleeding disorder), body mass index, ASA class, preoperative albumin levels, unintentional preoperative weight loss, wound classification, pathological diagnosis and stage (T and N stages), and gland texture) and the outcomes of interest was first tested using univariate analysis. Then, variables having a significant association (p-value < 0.2) with the primary/secondary outcomes of the univariate analyses were entered into a multivariate model. Each final model included covariates with a p-value less than 0.05 using a stepwise backward elimination method.
Linear regression models were used to determine the adjusted differences in operative time and length of hospital stay between surgical approaches with adjustment for patient age, race, diabetes mellitus, hypertension, smoking, congestive heart failure, unintentional preoperative weight loss, ASA class, body mass index, neoadjuvant treatments, wound classification, pathological diagnosis, and soft gland texture. Results are presented in the form of adjusted odd ratios (aOR) and mean ratios, including 95% confidence intervals (CI) with a p-value < 0.05 for significance. Statistical analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA).

3. Results

A total of 5636 patients who underwent elective distal pancreatectomies between 2014 and 2019 were identified. Of these, 33.9% (n = 1913) underwent LDP, 13.2% (n = 741) HALDP, and 52.9% (n = 2982) ODP. Baseline demographics across the three approaches are shown in Table 1. Patient age was similar for LDP, HALDP and ODP approaches, and most patients were females (p = 0.002) (Table 1). Use of the different approaches remained the same between 2014 to 2019: LDP (from 32.9% to 33.2%); HALDP (13.8% to 11.7%); ODP (53.4% to 55.1%); p = 0.249 (Figure 1).
Patients who underwent ODP were more likely to be diabetic (26.2%, p < 0.001), have a higher ASA class (66.5%, p < 0.001), have more preoperative weight loss (7.0%, p < 0.001), history of bleeding disorder (3.8%, p = 0.017) and higher clinical stage (Table 1). There were no differences in the other comorbidities such as smoking status, preoperative steroid use, COPD, and malnourishment between the different approaches. Patients who underwent LDP and HALDP more often had pancreatic cysts compared to patients who underwent ODP (LDP 29.6% vs. HALDP 27.5% vs. ODP 22.5%, p < 0.01). Adenocarcinoma was more common in patients who underwent ODP (LDP 18.5% vs. HALDP 26.6% vs. ODP 40.2%, p < 0.01).

3.1. Surgical Site Infection

In unadjusted analysis, compared with the LDP approach, surgical site infection rates were more frequent in the HALDP and ODP approaches (1.2% vs. 2.6% vs. 2.8%, respectively, p = 0.01) (Table 2). After adjustment for confounders, the LDP approach was associated with a significantly lower likelihood of surgical site infection (aOR 0.25, 95% CI 0.07–0.84, p = 0.03) when compared to ODP. There was no difference in the likelihood of surgical site infection when HALDP was compared to the ODP approach (aOR 0.59, 95% CI 0.17–0.03, p = 0.40) (Table 3).

3.2. Operative Times

In unadjusted analysis, operative times were similar between patients who underwent LDP, HALDP, and ODP approaches (LDP 192 min vs. HALDP 193 min vs. ODP 191 min, p = 0.59). However, after adjustment for confounders, the LDP approach showed slightly longer operative times than ODP (+10 min; 95% CI 0.53–19.99, p = 0.04). There was no difference in the adjusted operative time when HALDP was compared to ODP (+5.4 min; 95% CI −7.88–18.70, p = 0.80).

3.3. Secondary Endpoints

Overall and significant complication rates differed between approaches (overall complications LDP 24.3% vs. HALDP 23.9% vs. ODP 31.6%, p < 0.01; significant complications LDP 17.6% vs. HALDP 17.7% vs. ODP 25.3%, p < 0.01) (Table 2). After adjustment for confounders, LDP and HALDP approaches were associated with decreased odds of overall complications when compared to ODP LDP aOR 0.66, 95% CI 0.50–0.87, p < 0.01; HALDP aOR 0.56, 95% CI 0.38–0.84, p < 0.01). Similarly, both LDP and HALDP approaches were associated with decreased odds of significant complications compared to ODP (LDP OR 0.63, CI 0.46–0.85, p < 0.01; HALDP OR 0.65, 95% CI 0.42–0.99, p < 0.05, respectively) (Table 3). There was no difference in the odds of developing clinically-relevant (B/C) postoperative pancreatic fistula after LDP or HALDP compared to ODP (LDP aOR 1.28, 95% CI 0.93–1.78, p = 0.13; HALDP aOR 0.71, 95% CI 0.42–1.22, p = 0.22). LDP and HALDP approaches were also associated with a decreased likelihood of blood transfusion compared to ODP (LDP aOR 0.40, 95% CI 0.22–0.74, p < 0.01; HALDP aOR 0.40, 95% CI 0.17–0.98, p < 0.05) (Table 3).
Length of hospital stay was shorter in the LDP approach when compared to HALDP and ODP (LDP 4 days vs. HALDP 5 days vs. OPD 6 days; p < 0.01) (Table 2). After adjustment for confounders, both LDP (−0.26, 95% CI −0.31–−0.22, p < 0.01) and HALDP (−0.26, 95% CI −0.32–−0.20, p < 0.01) were associated with a significantly shorter length of hospital stay when compared to ODP. There was no difference in readmission rates between approaches (LDP 14.1% vs. HALDP 15.7% vs. ODP 15%, p = 0.55).

4. Discussion

This large study explores similarities and differences between surgical approaches for distal pancreatectomy in the modern era. We found that the total laparoscopic approach was associated with the lowest risk of surgical site infection compared with either the hand-assisted or open approaches. After adjustment, the association between the total laparoscopic approach and the lower odds of surgical site infection remained statistically significant. No difference in the odds of surgical site infection between the hand-assisted and open distal pancreatectomy approaches was found. Adjusted operative times were longer in the total laparoscopic approach by ten minutes. Both total laparoscopic and hand-assisted approaches were associated with lower odds of overall and significant complications, and shorter lengths of hospital stay. Despite these similarities and differences, the use of any of the three approaches remained the same over the past six years.
Previous studies have been inconsistent regarding surgical site infection rates between minimally invasive and open approaches in distal pancreatectomy. A meta-analysis from 2011 by Venkat et al. that included 733 laparoscopic and 1041 open distal pancreatectomies, demonstrated a lower risk of surgical site infection in the laparoscopic group (OR 0.45) [5]. In contrast, a recent randomized control trial that compared 51 laparoscopic vs. 57 open distal pancreatectomies found no differences in surgical site infection rates between approaches [16]. However, neither of these studies considered or included patients who underwent hand-assisted distal pancreatectomy. For example, Venkat et al.’s meta-analysis study defined the laparoscopic group as patients who underwent distal pancreatectomy with and without hand assistance, making no further distinction between approaches in their analysis. Moreover, the randomized control trial by de Rooiji et al. only included laparoscopic and robotic approaches [16]. Our study found a significant association between surgical approach and surgical site infection. In particular, the total laparoscopic approach had a lower risk of surgical site infection, but the hand-assisted approach had a similar risk to open distal pancreatectomy. Therefore, it is important to make the distinction between the total laparoscopic and the hand-assisted approaches when it comes to surgical site infection. Another difference in our study is that we were able to use a contemporary cohort and adjust for important confounders that could have potentially influenced the development of surgical site infection, such as wound classification and soft pancreatic gland texture [17].
The underlying mechanism of the association between distal pancreatectomy approaches and superficial surgical site infection may be related to the increased length of the incision required in the hand-assisted technique [11]. The hand-assisted approach requires about a 6–8 cm incision in the upper middle line to place the hand-port [14,16], which is typically longer than the incision needed for specimen extraction in the total laparoscopic approach. The continuous pressure exerted between the hand port and the abdominal wall, and the frequent reintroductions of the surgeon’s hand could increase tissue trauma and ischemia, making the surgical site more prone to infections [12,17,18,19,20,21].
Surgical site infection is associated with significant morbidity and cost, especially after pancreatectomy [19,22,23]. Surgical site infection also contributes to an increased burden on the healthcare system; on average, surgical site infection increases hospital costs by an average of $11,462 after major hepatopancreatobiliary surgeries [21]. Although anecdotally considered innocuous compared to other potentially devastating complications after pancreatectomy, such as grade C postoperative pancreatic fistula, surgical site infection is clinically-relevant and should be mitigated to improve patient outcomes and minimize burdens on the healthcare system [17,21].
Our study found that the total laparoscopic approach was associated with increased operative times. While the difference between the total laparoscopic and open groups is statistically significant, an argument can be made that the 10 min operative time difference may not be clinically relevant. Similar to our results, the LEOPARD trial demonstrated longer operative times in patients who underwent total laparoscopic distal pancreatectomy when compared to the open (217 vs. 179 min) [16]. In another study, Gamboa et al. reported their experiences on the short-term outcomes of 433 patients who underwent minimally invasive and open distal pancreatectomy at two medical centers [14]. However, the majority (89%) underwent pure laparoscopic distal pancreatectomy and only a small number of patients (11%) underwent hand-assisted distal pancreatectomy. Their unadjusted analysis found shorter operative times in the hand-assisted group than in the total laparoscopic group (−24 min). While we found similar results, the study by Gamboa et al. did not adjust for confounders that may have impacted surgical time such as comorbidities, pathological diagnosis, and vascular resections. Our results add the advantage of demonstrating the findings pertaining to the hand-assisted approach with accounting for confounders.
Both univariate and multivariable analyses showed lower overall complications and significant complications in the total laparoscopic and hand-assisted approaches when compared to open, which are consistent with previous studies [5,14]. However, in a retrospective analysis that included 1667 patients and compared patient outcomes by surgical approach in mucinous cystic neoplasms, no differences were found in complication rates [13]. Specifically, this study that compared 46 patients who underwent hand-assisted vs. 76 patients who underwent total laparoscopic or robotic approaches found no differences in postoperative and major complications. The authors also compared the hand-assisted approach vs. 153 patients who underwent open distal pancreatectomy and did not find statistical differences in postoperative and major complications. However, unlike the present study, their analysis was limited both by a small sample and the absence of adjustment for confounders.
Our study is limited by its retrospective nature. NSQIP does not include data on why a certain surgical approach was chosen. NSQIP only includes postoperative outcomes within 30 days; there is no data available on long-term outcomes including the development of an incisional hernia. NSQIP does not include data on surgeon or hospital volume nor type of facility (i.e., academic vs. community), which may be associated with different surgical approaches. Additionally, CPT codes used in NSQIP do not specify who underwent spleen-preserving distal pancreatectomy and who did not. However, the use of NSQIP data allows for the analysis of a large sample size which includes diverse institutions and surgeons, therefore reducing overall bias. Additionally, our study provides a unique perspective by analyzing surgical outcomes by the type of minimally invasive approach. Previous studies have typically grouped the two approaches under one “minimally invasive” group. By separating the hand-assisted and total laparoscopic approaches, we were able to provide more granular results on the outcomes of interest.
Our findings have important implications for clinical and future research. Our results suggest that while the hand-assisted approach shares similarities with the total laparoscopic approach, there are also important differences, such as the rates of surgical site infection. HALDP could be used as an alternative option to convert from the total laparoscopic approach in cases where dissection is difficult, unclear anatomy or the risk of hemorrhage is high. It may also be used in cases of malignancy, where HALDP facilitates palpation of tumor and staging and can facilitate dissection for voluminous lesions [24]. Future research should consider separately analyzing patients who underwent hand-assisted distal pancreatectomy from those who had total laparoscopic distal pancreatectomy as they may confer different outcomes. While surgeon comfort and experience should decide the operative approach, there are cases that may be more suitable for the hand-assisted approach such as those with expected technical difficulty or dissection and thus cannot be completed laparoscopically. The hand-assisted approach is still associated with better outcomes compared to the open approach.

5. Conclusions

Compared to open distal pancreatectomy, total laparoscopic distal pancreatectomy is associated with improved rates of surgical site infection. However, there was no difference in surgical site infection rates between open and hand-assisted distal pancreatectomy. Total laparoscopic distal pancreatectomy is associated with a slightly longer operative time (+10 min only). Surgeon comfort and experience should decide the operative approach, but it is important to discuss the differences between these approaches with patients. Further studies are needed to evaluate the direct benefits of hand-assist, particularly in the setting of conversion from laparoscopic as well as a postoperative incisional hernia.

Author Contributions

F.R.-H.: Conceptualization, Writing—Original Draft, Writing—Review and Editing, Visualization, Project administration. S.M.: Conceptualization, Writing—Original Draft, Writing—Review and Editing, Visualization, Project administration. P.M.: Writing—Original Draft, Writing—Review and Editing. N.R.: Writing—Original Draft, Writing—Review and Editing. L.C.: Writing—Original Draft, Writing—Review and Editing. P.C.C.: Writing—Original Draft, Writing—Review and Editing. A.A.G.: Writing—Original Draft, Writing—Review and Editing. K.H.: Conceptualization, Writing—Review and Editing. A.V.M.: Conceptualization, Writing—Review and Editing. E.N.: Conceptualization, Writing—Review and Editing. C.C.: Conceptualization, Writing—Review and Editing. K.S.K.: Conceptualization, Writing—Review and Editing. A.A.: Conceptualization, Writing—Review and Editing. M.A.A.: Conceptualization, Methodology, Software, Validation, Formal analysis, Investigation, Resources, Writing—Review and Editing, Supervision, Project administration. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Ethical review and approval were waived for this study due to the de-identified nature of the data.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data that support these findings are housed with the American College of Surgeons. Data are available in a de-identified fashion to participants of the NSQIP Program.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Kelley, W.E. The Evolution of Laparoscopy and the Revolution in Surgery in the Decade of the 1990s. J. Soc. Laparoendosc. Surg. 2008, 12, 351–357. [Google Scholar]
  2. Polychronidis, A.; Laftsidis, P.; Bounovas, A.; Simopoulos, C. Twenty Years of Laparoscopic Cholecystectomy: Philippe Mouret—March 17, 1987. J. Soc. Laparoendosc. Surg. 2008, 12, 109–111. [Google Scholar]
  3. Jayaraman, S.; Gonen, M.; Brennan, M.F.; D’Angelica, M.I.; DeMatteo, R.P.; Fong, Y.; Jarnagin, W.R.; Allen, P.J. Laparoscopic Distal Pancreatectomy: Evolution of a Technique at a Single Institution. J. Am. Coll. Surg. 2010, 211, 503–509. [Google Scholar] [CrossRef] [PubMed]
  4. Borja-Cacho, D.; Al-Refaie, W.B.; Vickers, S.M.; Tuttle, T.M.; Jensen, E.H. Laparoscopic Distal Pancreatectomy. J. Am. Coll. Surg. 2009, 209, 758–765. [Google Scholar] [CrossRef] [PubMed]
  5. Venkat, R.; Edil, B.H.; Schulick, R.D.; Lidor, A.O.; Makary, M.A.; Wolfgang, C.L. Laparoscopic distal pancreatectomy is associated with significantly less overall morbidity compared to the open technique: A systematic review and me-ta-analysis. Ann. Surg. 2012, 255, 1048–1059. [Google Scholar] [CrossRef] [PubMed]
  6. Yang, I.; Boushey, R.P.; Marcello, P.W. Hand-assisted laparoscopic colorectal surgery. Technol. Coloproctol. 2013, 17, 23–27. [Google Scholar] [CrossRef]
  7. Kimura, Y.; Hirata, K.; Mukaiya, M.; Mizuguchi, T.; Koito, K.; Katsuramaki, T. Hand-assisted laparoscopic pylorus-preserving pancreaticoduodenectomy for pancreas head disease. Am. J. Surg. 2005, 189, 734–737. [Google Scholar] [CrossRef]
  8. Shinchi, H.; Takao, S.; Noma, H.; Mataki, Y.; Iino, S.; Aikou, T. Hand-assisted laparoscopic distal pancreatectomy with minilaparotomy for distal pancreatic cystadenoma. Surg. Laparosc. Endosc. Percutan. Technol. 2001, 11, 139–143. [Google Scholar] [CrossRef]
  9. Sugita, H.; Kuroki, H.; Akiyama, T.; Daitoku, N.; Tashima, R.; Tanaka, H.; Honda, S.; Hirota, M. Hand-assisted laparoscopic spleen-preserving distal pancreatectomy combined with laparoscopic distal gastrectomy for the treatment of pancreatic neuro-endocrine tumor with early gastric cancer: Report of a case. Int. J. Surg. Case Rep. 2016, 28, 258–261. [Google Scholar] [CrossRef] [Green Version]
  10. Leraas, H.J.; Ong, C.T.; Sun, Z.; Adam, M.A.; Kim, J.; Gilmore, B.F.; Ezekian, B.; Nag, U.S.; Mantyh, C.R.; Migaly, J. Hand-Assisted Laparoscopic Colectomy Improves Perioperative Outcomes Without Increasing Operative Time Compared to the Open Approach: A National Analysis of 8791 Patients. J. Gastrointest. Surg. 2017, 21, 684–691. [Google Scholar] [CrossRef]
  11. Gilmore, B.F.; Sun, Z.; Adam, M.; Kim, J.; Ezekian, B.; Ong, C.; Migaly, J.; Mantyh, C.R. Hand-Assisted Laparoscopic Versus Standard Laparoscopic Colectomy: Are Outcomes and Operative Time Different? J. Gastrointest. Surg. 2016, 20, 1854–1860. [Google Scholar] [CrossRef] [PubMed]
  12. Bishawi, M.; Fakhoury, M.; Denoya, P.I.; Stein, S.; Bergamaschi, R. Surgical site infection rates: Open versus hand-assisted colorectal resections. Technol. Coloproctol. 2014, 18, 381–386. [Google Scholar] [CrossRef] [PubMed]
  13. Postlewait, L.M.; Ethun, C.G.; McInnis, M.R.; Merchant, N.; Parikh, A.; Idrees, K.; Isom, C.A.; Hawkins, W.; Fields, R.C.; Strand, M.; et al. The Hand-Assisted Laparoscopic Approach to Resection of Pancreatic Mucinous Cystic Neoplasms: An Underused Technique? Am. Surg. 2018, 1, 56–62. [Google Scholar] [CrossRef]
  14. Gamboa, A.C.; Aveson, V.G.; Zaidi, M.Y.; Lee, R.M.; Jarnagin, W.R.; Allen, P.J.; Drebin, J.A.; Kingham, T.P.; DeMatteo, R.P.; Sarmiento, J.M.; et al. Lending a hand for laparoscopic distal pancreatectomy: The optimal approach? HPB 2020, 22, 690–701. [Google Scholar] [CrossRef] [PubMed]
  15. About ACS NSQIP. In American College of Surgeons. Available online: http://www.facs.org/quality-programs/acs-nsqip/about (accessed on 29 December 2021).
  16. de Rooij, T.; van Hilst, J.; van Santvoort, H.; Boerma, D.; van den Boezem, P.; Daams, F.; van Dam, R.; Dejong, C.; van Duyn, E.; Dijkgraaf, M.; et al. Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD): A Multicenter Patient-blinded Randomized Controlled Trial. Ann. Surg. 2019, 269, 2–9. [Google Scholar] [CrossRef] [PubMed]
  17. McCracken, E.K.E.; Mureebe, L.; Blazer, D.G. Minimally Invasive Surgical Site Infection in Procedure-Targeted ACS NSQIP Pancreaticoduodenectomies. J. Surg. Res. 2019, 233, 183–191. [Google Scholar] [CrossRef]
  18. You, L.; Zhao, W.; Hong, X.; Ma, L.; Ren, X.; Shao, Q.; Du, Y.; Cong, L.; Zhao, Y. The Effect of Body Mass Index on Surgical Outcomes in Patients Undergoing Pancreatic Resection: A Systematic Review and Meta-Analysis. Pancreas 2016, 45, 796–805. [Google Scholar] [CrossRef] [PubMed]
  19. Sanford, D.E.; Strasberg, S.M.; Hawkins, W.G.; Fields, R.C. The impact of recent hospitalization on surgical site infection after a pancreatectomy. HPB 2015, 17, 819–823. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Okano, K.; Hirao, T.; Unno, M.; Fujii, T.; Yoshitomi, H.; Suzuki, S.; Satoi, S.; Takahashi, S.; Kainuma, O.; Suzuki, Y. Postoperative infectious complications after pancreatic resection. Br. J. Surg. 2015, 102, 1551–1560. [Google Scholar] [CrossRef]
  21. Ceppa, E.P.; Pitt, H.A.; House, M.G.; Kilbane, E.M.; Nakeeb, A.; Schmidt, C.M.; Zyromski, N.J.; Lillemoe, K.D. Reducing surgical site infections in hepatopancreato-biliary surgery. HPB 2013, 15, 384–391. [Google Scholar] [CrossRef] [Green Version]
  22. Badia, J.M.; Casey, A.L.; Petrosillo, N.; Hudson, P.; Mitchell, S.; Crosby, C. Impact of surgical site infection on healthcare costs and patient outcomes: A systematic review in six European countries. J. Hosp. Infect. 2017, 96, 1–15. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Piednoir, E.; Robert-Yap, J.; Baillet, P.; Lermite, E.; Christou, N. The Socioeconomic Impact of Surgical Site Infections. Front. Public Health 2021, 9, 712461. [Google Scholar] [CrossRef] [PubMed]
  24. Donisi, G.; Zerbi, A. What role does hand-assistance have in minimally invasive pancreatic surgery? Mini-Invasive Surg. 2021, 5, 38. [Google Scholar] [CrossRef]
Figure 1. Time Trends of All Patients Undergoing Distal Pancreatectomy by Surgical Approach.
Figure 1. Time Trends of All Patients Undergoing Distal Pancreatectomy by Surgical Approach.
Cancers 14 05625 g001
Table 1. Demographic and Preoperative Clinical Characteristics of Patients Undergoing Distal Pancreatectomy in NSQIP (2014–2019).
Table 1. Demographic and Preoperative Clinical Characteristics of Patients Undergoing Distal Pancreatectomy in NSQIP (2014–2019).
Open
(n = 2982)
Hand-assisted
(n = 741)
Total
Laparoscopic
(n = 1913)
p Value
Age (years) 0.374
<651520 (51.0 %)397 (53.6%)1021 (53.4%)
65–801302 (43.7%)312 (42.1%)794 (41.5%)
>80160 (5.4%)32 (4.3%)98 (5.1%)
Female sex1675 (56.2%)413 (55.7%)1166 (61.0%)0.002
Race <0.001
White2262 (75.9%)578 (78.0%)1326 (69.3%)
Black272 (9.1%)69 (9.3%)158 (8.3%)
Asian91 (3.1%)22 (3.0%)113 (5.9%)
Other14 (0.5%)3 (0.4%)13 (0.7%)
Hispanic130 (4.4%)41 (5.5%)95 (5.0%)0.317
BMI (kg/m2, Median, IQR)27.63
(24.17–31.78)
28.58 (24.79–33.3)28.21 (24.27–32.6)<0.001
ASA Class <0.001
129 (1.0%)10 (1.4%)32 (1.7%)
2829 (27.8%)234 (31.6%)662 (34.6%)
31984 (66.5%)466 (62.9%)1135 (59.3%)
4136 (4.6%)30 (4.1%)82 (4.3%)
Diabetes Mellitus <0.001
No2201 (73.8%)566 (76.4%)1515 (79.2%)
Non–Insulin–Dependent 337 (11.3%)63 (8.5%)123 (6.4%)
Insulin–Dependent444 (14.9%)112 (15.1%)275 (14.4%)
Smoking482 (16.2%)103 (13.9%)266 (13.9%)0.061
Dyspnea167 (5.6%)41 (5.5%)118 (6.2%)0.674
COPD121 (4.1%)28 (3.8%)91 (4.8%)0.391
CHF15 (0.5%)7 (0.9%)2 (0.1%)0.008
Hypertension requiring medications1484 (49.8%)400 (54.0%)926 (48.4%)0.036
Steroids Use115 (3.9%)38 (5.1%)74 (3.9%)0.263
Weight loss (≥10%)210 (7.0%)38 (5.1%)57 (3.0%)<0.001
Bleeding Disorder113 (3.8%)21 (2.8%)45 (2.4%)0.017
Preoperative Albumin (g/dL, Median, IQR)4.1 (3.9–4.4)4.1 (3.8–4.4)4.2 (3.9–4.4)0.003
Pathological
Diagnosis
<0.001
Adenocarcinoma1198 (40.2%)197 (26.6%)354 (18.5%)
Neuroendocrine Tumor516 (17.3%)204 (27.5%)567 (29.6%)
Pancreatitis211 (7.1%)25 (3.4%)63 (3.3%)
Pancreatic Cyst670 (22.5%)224 (30.2%)703 (36.6%)
Neoadjuvant Chemotherapy407 (13.7%)29 (3.9%)60 (3.1%)<0.001
T Stage <0.001
Not Applicable1121 (37.6%)322 (43.5%)967 (50.6%)
T1373 (12.5%)124 (16.7%)302 (15.8%)
T2550 (18.4%)129 (17.4%)331 (17.3%)
T3813 (27.3%)148 (20.0%)275 (14.4%)
T436 (1.2%)1 (0.1%)5 (0.3%)
N Stage <0.001
Not Applicable993 (33.3%)272 (36.7%)603 (31.5%)
N0693 (23.2%)110 (14.8%)220 (11.5%)
N11121 (37.6%)323 (43.6%)970 (50.7%)
Wound Classification <0.001
Clean433 (14.5%)88 (11.9%)362 (18.9%)
Clean–Contaminated2346 (78.7%)631 (85.2%)1488 (77.8%)
Contaminated187 (6.3%)21 (2.8%)59 (3.1%)
Dirty/Infected16 (0.5%)1 (0.1%)4 (0.2%)
Soft Pancreas859 (28.8%)147 (19.8%)443 (23.2%)<0.001
Abbreviations: NSQIP: American College of Surgeons National Surgical Quality Improvement; IQR: Interquartile Range; BMI: Body Mass Index; COPD: Chronic Obstructive Pulmonary Disease; CHF: Congestive Heart Failure. Kruskal–Wallis test was used for continuous variables and χ2 test for categorical variables.
Table 2. Distribution of Outcomes in Patients Undergoing Distal Pancreatectomy by Surgical Approach.
Table 2. Distribution of Outcomes in Patients Undergoing Distal Pancreatectomy by Surgical Approach.
Open
(n = 2982)
Hand-Assisted
(n = 741)
Total Laparoscopic
(n = 1913)
p Value
Overall Complications *943 (31.6%)177 (23.9%)465 (24.3%)<0.001
Significant
Complications +
753 (25.3%)131 (17.7%)337 (17.6%)<0.001
CR–POPF372 (12.5%)119 (16.1%)290 (15.2%)0.003
Blood Transfusion275 (9.2%)19 (2.6%)53 (2.8%)<0.001
Discharge to Facility138 (4.6%)36 (4.9%)53 (2.3%)0.002
Surgical Site Infection82 (2.8%)19 (2.6%)23 (1.2%)0.001
Operative Time (min, Median, IQR)191 (139–255)193 (150–246)192 (149–244)0.585
LOS (days, Median, IQR)6 (5–7)5 (4–6)4 (4–6)<0.001
Abbreviations: IQR: Interquartile Range; Min: Minutes; CR-POPF: Clinically Relevant (Grade B/C) Postoperative Pancreatic Fistula; LOS: Length of Stay. * Overall complications composite included infectious (deep wound infection and dehiscence, abscess, urinary tract infection, post-operative sepsis, post-operative septic shock), pulmonary (pneumonia, reintubation, and ventilator wean failure), cardiovascular (deep vein thrombosis, pulmonary embolism, stroke, cardiac arrest, myocardial infarction) and renal complications (acute kidney failure), post-operative blood transfusion, reoperation, 30-day readmission, and 30-day mortality. + Significant complications composite included infectious (deep wound infection and dehiscence, abscess, post-operative sepsis, post-operative septic shock), pulmonary (pneumonia, reintubation, and ventilator wean failure), cardiovascular (deep vein thrombosis, pulmonary embolism, stroke, cardiac arrest, myocardial infarction), post-operative blood transfusion, reoperation, 30-day readmission, and 30-day mortality. Kruskal–Wallis test was used for continuous variables and χ2 test for categorical variables.
Table 3. Multivariable Logistic Regression with backward elimination of Patients Undergoing Hand-Assisted or Total Laparoscopic Compared to Open Distal Pancreatectomy.
Table 3. Multivariable Logistic Regression with backward elimination of Patients Undergoing Hand-Assisted or Total Laparoscopic Compared to Open Distal Pancreatectomy.
aOR95% CIp-Value
Surgical Site Infection
OpenReference
Hand-assisted0.590.17–2.030.403
Total Laparoscopic0.250.07–0.840.025
Overall Complications
OpenReference
Hand-assisted0.560.38–0.840.005
Total Laparoscopic0.660.50–0.870.003
Significant Complications
OpenReference
Hand-assisted0.650.42–0.990.046
Total Laparoscopic0.630.46–0.850.003
CR-POPF
OpenReference
Hand-assisted0.710.42–1.220.215
Total Laparoscopic1.280.93–1.780.133
Transfusion
OpenReference
Hand-assisted0.400.17–0.980.045
Total Laparoscopic0.400.22–0.740.003
Discharge to Facility
OpenReference
Hand-assisted0.800.36–1.780.579
Total Laparoscopic0.440.23–0.840.013
CR-POPF: Clinically Relevant (Grade B/C) Postoperative Pancreatic Fistula, aOR: Adjusted Odds Ratio, CI: Confidence Interval. Adjusting for age, sex, race, diabetes mellitus, hypertension, smoking, congestive heart failure, weight loss, wound classification, pathological diagnosis, body mass index, ASA class, and soft gland texture.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Romero-Hernandez, F.; Mohamedaly, S.; Miller, P.; Rodriguez, N.; Calthorpe, L.; Conroy, P.C.; Ganjouei, A.A.; Hirose, K.; Maker, A.V.; Nakakura, E.; et al. Minimally Invasive Distal Pancreatectomy Techniques: A Contemporary Analysis Exploring Trends, Similarities, and Differences to Open Surgery. Cancers 2022, 14, 5625. https://doi.org/10.3390/cancers14225625

AMA Style

Romero-Hernandez F, Mohamedaly S, Miller P, Rodriguez N, Calthorpe L, Conroy PC, Ganjouei AA, Hirose K, Maker AV, Nakakura E, et al. Minimally Invasive Distal Pancreatectomy Techniques: A Contemporary Analysis Exploring Trends, Similarities, and Differences to Open Surgery. Cancers. 2022; 14(22):5625. https://doi.org/10.3390/cancers14225625

Chicago/Turabian Style

Romero-Hernandez, Fernanda, Sarah Mohamedaly, Phoebe Miller, Natalie Rodriguez, Lucia Calthorpe, Patricia C. Conroy, Amir Ashraf Ganjouei, Kenzo Hirose, Ajay V. Maker, Eric Nakakura, and et al. 2022. "Minimally Invasive Distal Pancreatectomy Techniques: A Contemporary Analysis Exploring Trends, Similarities, and Differences to Open Surgery" Cancers 14, no. 22: 5625. https://doi.org/10.3390/cancers14225625

APA Style

Romero-Hernandez, F., Mohamedaly, S., Miller, P., Rodriguez, N., Calthorpe, L., Conroy, P. C., Ganjouei, A. A., Hirose, K., Maker, A. V., Nakakura, E., Corvera, C., Kirkwood, K. S., Alseidi, A., & Adam, M. A. (2022). Minimally Invasive Distal Pancreatectomy Techniques: A Contemporary Analysis Exploring Trends, Similarities, and Differences to Open Surgery. Cancers, 14(22), 5625. https://doi.org/10.3390/cancers14225625

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop